Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Once-Daily Versus Twice-Daily Insulin Glargine in the Management of Patients With Pregestational Diabetes Requiring Insulin

NCT07224893 is registered in ClinicalTrials.gov with Eastern Virginia Medical School as lead sponsor.

NCT NCT07224893
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07224893 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Once-Daily Versus Twice-Daily Insulin Glargine in the Management of Patients With Pregestational Diabetes Requiring Insulin
Lead sponsor
Eastern Virginia Medical School
Phase
Phase 4
Overall status
Recruiting
Start date
May 18, 2026
Completion date
December 1, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pregestational diabetes, pregnancy